An official website of the United States government
Figure 3.4. Rates of reported acute hepatitis C virus infection, by age group — United States, 2004–2019
Since 2010, rates of reported acute hepatitis C increased among almost all age groups of ≥20 years. The rate of acute hepatitis C has remained the highest among persons aged 20–39 years, similar to age groups at highest risk for fatal overdose in the United States and age at initiation of injection drug use among certain US populations. Compared with 2018, the greatest increase in the rates of acute hepatitis C were observed among those aged 40–49 years (31% increase), followed by those aged 30–39 years (23% increase). For the first time in more than a decade, the rate of acute hepatitis C decreased slightly among those aged 20–29 years. Rates have consistently been lowest among those aged <20 years or ≥60 years; however, rates have been increasing among those aged ≥60 years since 2015.
Source: Jalal H, Buchanich JM, Sinclair DR, et al. Age and generational patterns of overdose death risk from opioids and other drugs. Nat Med 2020;26:699–704. doi: 10.1038/s41591-020-0855-y.
- Figure 3.1. Number of reported acute hepatitis C virus infection cases and estimated infections — United States, 2012–2019
- Figure 3.2. Rates of reported acute hepatitis C virus infections, by state — United States, 2018–2019
- Figure 3.3. Rates of reported acute hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Figure 3.4. Rates of reported acute hepatitis C virus infection, by age group — United States, 2004–2019
- Figure 3.5. Rates of reported acute hepatitis C virus infection, by sex — United States, 2004–2019
- Figure 3.6. Rates of reported acute hepatitis C virus infection, by race/ethnicity — United States, 2004–2019
- Figure 3.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2019
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases, by sex and age — United States, 2019
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 3.1. Number and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
- Table 3.2. Number and rates of reported cases of acute hepatitis C, by demographic characteristics — United States 2015–2019
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2019
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.5. Number and rates of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.6. Number and rates of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2019
- Table 3.7. Number and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 3.8. Number and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019